Navigation Links
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Date:4/25/2012

ey and the surrounding region is part of a broad international expansion strategy for the Company. Amgen established an affiliate in Turkey in 2010 and currently markets two products, with plans to develop its robust pipeline of clinical candidates for the benefit of patients in Turkey, as well as other markets around the world.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

Amgen Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2011, and in our periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. 

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company's results may be affected by our ability to successfully market both new and existing pro
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen Announces Webcast of 2012 First Quarter Financial Results
2. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
3. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
4. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
5. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
6. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
7. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
8. Amgen Announces Final Results of Its Tender Offer
9. Amgen Announces Preliminary Results of Its Tender Offer
10. AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by Epix Pharmaceuticals, Inc. and Amgen.
11. Amgen Statement on European Investor Visit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... -- ChemImage founder and CTO, Patrick J. Treado ... innovative diagnostic procedure for the detection of colorectal cancer ... (SPEC) conference in Krakow, Poland . ... in vitro Diagnostics for Detection of Colorectal Cancer Using ... poster session on Tuesday, August 19, 2014 from 6:30 ...
(Date:8/19/2014)... 19, 2014 Research and Markets has ... of Material, by Technology, by Application & by Region- Global ... The demand for membranes is estimated to ... market to $29.31 billion Membrane technology was first ... as water filtration and kidney dialysis. In modern times, membranes ...
(Date:8/19/2014)... MAHWAH, N.J. , Aug. 19, 2014  Stryker Corporation,s ... TOUR and Champions Tour, is bringing its message of joint ... New Jersey this week at The Barclays.  ... will be in the Spectator Village near the 17 th ... Paramus starting on Thursday, August 21 st . ...
Breaking Medicine Technology:ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 2Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 3Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 4Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 5
... Oct. 19, 2009 Amylin Pharmaceuticals, Inc. (Nasdaq: ... obesity program will be presented at Obesity 2009, the ... be held in Washington, D.C. October 24-28. Phase 2 ... be the subject of a late-breaking oral presentation. Obesity ...
... , SILVER SPRING, Md., Oct. 19 The U.S. Food ... to be approved for kidney cancer since 2005. , (Logo: ... oral medication that interferes with angiogenesis, the growth of new ... , Votrient is intended for people with advanced renal ...
Cached Medicine Technology:Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 2Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 3Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 4Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 5FDA Approves New Treatment for Advanced Form of Kidney Cancer 2
(Date:8/20/2014)... According to a new market research report ... Crystal, Microblinds, Thermographic and Photochromics), by application (Architectural, ... geography - Global Forecast to 2014 - 2020", ... market was worth $1581.4 Million in 2013, and ... at an estimated CAGR of 20% from 2014 ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... leading nonprofit authority on the use of health ... announced the full agenda for its annual fall ... IT Efficiency. WEDI-Con 2014 will take place at ... 20-23, 2014, attracting a diverse cross-section of payers, ...
(Date:8/20/2014)... Fresh from the cradle of a world-class running ... starting blocks. , Urbini, a new collection of versatile baby ... Avi jogger to its lineup. , The Avi has ... inspired by the latest racing styles and a set of ... jogger offers a swift, smooth ride on runs, power-walks and ...
(Date:8/20/2014)... Los Angeles, CA (PRWEB) August 20, 2014 ... clinic has found a cure for it. With extensive research ... Therapy provider named ‘MetroMD’ claims to have perfected the art ... give you a brand new younger look with their revolutionary ... the secrets of the 21st century fountain of youth, the ...
(Date:8/20/2014)... Doctors at the University of Hong Kong claim to ... mice by injecting them with a vaccine that changes their ... on its website. Click here to read the full ... Institute of Microbiology created a vaccine using a protein called ... the vaccine is designed to prevent mesothelioma cells from disabling ...
Breaking Medicine News(10 mins):Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 2Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 3Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 4Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 5Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2
... permission with European medicine regulators to begin selling its new ... in the US last month, and comes slightly earlier than ... be one of GSK's most promising pipeline drugs as well ... the sales of the drug could cross 2 bln used ...
... world who get uncomfortable after a heavy meal here is ... have proven that eating 6-8 walnuts (approx.40g) after a rich ... triggered of in the walls of arteries after a highly ... the Oct. 17 issue of the Journal of the American ...
... given to bowel cancer patients before the surgical removal ... risk of recurrence to 1 %. The usual ... of recurrence is there and once reappeared, treatment is ... conducted an international study, to compare the effect of ...
... after irrigation water samples tested positive for E. coli ... relaxed its advisory against eating fresh spinach. ... detected after a secondary water source temporarily used to ... the water got contaminated is still not clear. ...
... challenges parenting stereotypes; Today’s parents boast about the numerous classes ... and the many talents they possess. Competitive parents in their ... ‘super-kids’ , often smother their children with an over-dose of ... gizmos , play stations, and game boys… and Oh boy, ...
... Around 45 Iraqi children have arrived in Bahrain to receive ... to arrive in the coming days as part of an ... move Sunday came in response to a call to help ... composer Naseer Shamma, who is the head of the newly ...
Cached Medicine News:Health News:Walnuts May Help Fight Fat and Keep Arteries Supple 2
... if it is not the Flu? Streptococcus ... bacterial "flu-like" infections. The easy-to-use, rapid, urine-based ... within the new 4 hour guidelines. Rapid ... improved patient outcomes and lower overall health ...
Single Use Loading Units with Titanium Staplers for use with MULTIFIRE ENDO TA™ 30 12 mm (Single Use Staplers with Titanium Staplers)....
Single Use Loading Units (SULU's) Knifeless for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Single Use Loading Units (SULU's) with Titanium Staples for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Medicine Products: